Yi Shan ChaoChe-Wei WuYing-Chu LinChun-Wei TungPo-Yu ChenBing-hung ChenChien-chih ChiuChung-Jen ChenYing-Chi LinJih-Heng LiWen-Cheng ChenMing-Tsang WuHung-Yi ChuangMin-Liang KuoChai-Lin KaoHui-Ju HsiehChau-Chyun SheuChian-Hui LaiSebastian YuFang-Rong ChangJaya Kishore VandavasiSodio C.N. HsuHsing-Yin ChenRajalakshmanan EswaramoorthyBin-Nan WuYao-Hsiang ShihJau-Ling SuenChi-Chih HungHsiu-Hung WangShu-Hung HuangChie-Hong WangYi-Ting LinYan-Ren LinTzu-Pin WangWan-Chi TsaiChung-Ping ChengPo-Lin KuoChia-Hung YenYuan-Bin ChengTusty-Jiuan Hsieh
P108
Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsA Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaA Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCCRandomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) PatientsThe Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease CareTislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaThe HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 PatientsA Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusEfficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis TreatmentComparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line TherapyImproving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency DepartmentGLORIA-AF Registry Program - Second and Third PhasesThe Application of Thermal Stimulation on Functional Recovery of Stroke PatientsImproving Informed Consent Process for Trauma Patients in the Emergency DepartmentCAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesPhase IIb Study of STA-2 in Patients With Chronic Stable AnginaDexamethasone at Lower Concentration Ropivacaine in the Supraclavicular Nerve BlockEvaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanExtended Access of Momelotinib in Adults With MyelofibrosisThe Application of Wearable Technology to Improve the Physical Activity Level of People With Chronic Mental IllnessA Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsThe Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab TreatmentA Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis BA Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyNamed Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerLong-Term Outcomes of Ataluren in Duchenne Muscular DystrophySafety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseBI 836845 in Estrogen Receptor Positive Metastatic Breast CancerPh 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaStudy to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsSafety, Tolerability, and Antiviral Activity of GS-9688 in Viremic Adults With Chronic Hepatitis B Who Are Not Currently on TreatmentStudy to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
P6153
李成家Hung Wen-tungTing-Chao Chou王湘琦Lin Tzu-chi王正德高資敏柳林瑋許立民江自得Wei Fu-chan張宏榮Ho Chi-kungYang-Pei ChangChe-Wei WuGuei-Sheung LiuHsu-Huei WengKa-wo LeeHsien-Hung ChengChia-Yen DaiChang Po-yaHsu Shu-ching黃怡瑄Huei-Lih HwangTai-Heng ChenWei-Yu LinJiunn-Wei WangMing-Yen LinChih-Ho ChouTzu-Chun ChenChih-Chun WuBin-Nan WuTe-Wei HoPo-Liang LuChi-Chih HungShu-Hung HuangYi-Jing LueWen-Chien KoJhen-Hao JhanChang Wen-ying
P69
Q36706779-3887A57C-7425-4D2A-88AE-08FD51F81A20Q37836823-09036F0B-3C4E-45BB-841E-518FA119D461Q37840972-6640377A-16E2-403A-91D2-5E9C9A3EE085Q38639158-E31EEED0-0904-4DC1-92EE-1B6E19E584A0Q42791680-2B2F52CF-88C1-4D41-B9EB-722C690EF0C6Q42809763-B59671C3-EBB4-4132-A582-392E64CACA4FQ42893175-4B90B534-7F22-4A70-94C3-8BC56564F5FEQ43282392-B1F45907-945A-429C-94EC-F179A39486ADQ43370939-E6452CCA-352C-421C-B662-F40C69CE97B5Q44692215-F4CE5C42-EE5E-41D0-BDE4-970441B14C4BQ50241459-4120FD8D-FF40-4372-BD54-03AE8305160FQ54232667-759D72F4-6A9F-4407-805B-0E00325327CFQ54232667-96C59558-0C5B-4890-BC94-C1F88B5AE3B4Q56046954-14757A50-DF1F-4FB3-ABAD-2D9062959ED1Q56588181-09477397-F236-4FB6-878F-53516E03D553Q56613405-1BDD6372-385E-4DF2-9A55-6D53CAF7E9DDQ56999178-67743CD9-5C1B-4BBC-8666-81568E0995DDQ57018386-A6C603CD-9667-4D54-9437-427530717A1BQ57078844-C15BA4B5-A24F-47CE-A1B6-1D82DAD52C28Q57113150-36A29558-7C85-4D60-9F02-E8DA6E9FE1D3Q57209644-E2CD7596-499A-4AAE-8C57-20A470C566F7Q57552739-67D6EBC5-2C95-472A-9F0E-828D58175585Q57976204-58EA8468-4A16-4467-AD95-ACE0936ED570Q57976221-1320E9C7-D8D8-425D-978C-FBF289892A21Q58202917-6C6AFF31-8CF7-46E3-833A-08B9110FDDACQ58672165-358ABCE2-565C-4871-B4EA-B885B6CB8E2AQ59162596-C4ED86BA-335B-49C8-9561-415BBA12A87CQ59677295-7C900053-ED8B-4245-97FA-D7F8DCD86899Q59682121-D2A099A1-6470-4FBF-A5DA-61FA737BC221Q59689960-2E88C21B-78F3-4423-A0F7-1F43E785FB39Q59696215-864D783B-7542-493D-BCDC-A53855D8698BQ59696215-868733DA-51D9-4438-A2E5-467104E12A9CQ59703450-790B9543-3A84-4F9D-A2B4-CA97370B01C2Q59708643-22D76556-B121-4A8A-8980-9AB2187B21D6Q59770185-E77F5CA4-08BB-44A6-BB3B-F870597819F6Q60330128-A37E33B8-56B8-4ACD-ABC5-EC1FBA384E0BQ60503715-8D1F7D6F-7FA9-4C78-981A-F1AA2B201C80Q60651615-C77B7FDD-15D6-468F-A466-89032BFA1981Q60976362-BFE3EE82-19C6-4EE0-818D-647FF4B08B80Q61084527-4FC15017-03A5-42E4-AF44-7C2B370BFFEE
P108
description
Universität in der Republik China
@de
universitas di Republik Tiongkok
@id
universiteit in Taiwan
@nl
university
@en
אוניברסיטה בטאיוואן
@he
جامعة في كاوهسيونغ، تايوان
@ar
name
Kaohsiung Medical University
@en
Kaohsiung Medical University
@tl
Ko-hiông I-ha̍k Tāi-ha̍k
@nan
Prifysgol Meddygol Kaohsiung
@cy
高雄医学大学
@ja
高雄医学大学
@zh-hans
高雄醫學大學
@zh
高雄醫學大學
@zh-hant
高雄醫學大學
@zh-hk
가오슝 의학대학
@ko
type
label
Kaohsiung Medical University
@en
Kaohsiung Medical University
@tl
Ko-hiông I-ha̍k Tāi-ha̍k
@nan
Prifysgol Meddygol Kaohsiung
@cy
高雄医学大学
@ja
高雄医学大学
@zh-hans
高雄醫學大學
@zh
高雄醫學大學
@zh-hant
高雄醫學大學
@zh-hk
가오슝 의학대학
@ko
altLabel
Kaohsiung Medical University
@zh
Ko-hiông I-ha̍k-īⁿ
@nan
高醫
@zh
高醫大
@zh
高雄醫大
@zh
高雄醫學院
@zh
prefLabel
Kaohsiung Medical University
@en
Kaohsiung Medical University
@tl
Ko-hiông I-ha̍k Tāi-ha̍k
@nan
Prifysgol Meddygol Kaohsiung
@cy
高雄医学大学
@ja
高雄医学大学
@zh-hans
高雄醫學大學
@zh
高雄醫學大學
@zh-hant
高雄醫學大學
@zh-hk
가오슝 의학대학
@ko
P214
P244
P3153
P6366
P646
P131
P17
P213
0000 0000 9476 5696
P214
P2427
grid.412019.f
P244
P31
P3153
501100004694
P3417
Kaohsiung-Medical-University
P3500
P373
Kaohsiung Medical University
P3749
9581019033489439711